New data concerning risks of adverse pregnancy and fetal outcomes following maternal dolutegravir use

Researchers from the Antiretroviral Pregnancy Registry and European Pregnancy and Paediatric HIV Cohort Collaboration have jointly published data from their respective registries detailing the fetal outcomes of more than 300 dolutegravir exposed pregnancies. More information can be found here.